Introduction of an NT-proBNP assay to an acute admission unit - A 2-year audit

European Journal of Internal Medicine

Volumn 20, Issue 1, 2009, Pages 58-62

  Murtagh, Gillian ^a   Canniffe, Carla ^a   Mahgoub, Mohamed ^a   Blake, Liam ^a   McCarroll, Nuala ^a   Crowley, Vivion ^a   Bennett, Kathleen ^b   Silke, Bernard ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Congestive; Dyspnoea; Heart failure; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DYING; FEMALE; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORTALITY; OUTCOME ASSESSMENT; PREDICTION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC TESTS, ROUTINE; DYSPNEA; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; INPATIENTS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MEDICAL AUDIT; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 60349112936     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2008.04.021     Document Type: Article

References (27)

1. McCullough P.A., Philbin E.F., Spertus J.A., Kaatz S., Sandberg K.R., and Weaver W.D. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 39 1 (2002) 60-69
2. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., Baggish A.L., Chen A.A., Krauser D.G., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 8 (2005) 948-954
3. Maisel A., Hollander J.E., Guss D., McCullough P., Nowak R., Green G., et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44 6 (2004) 1328-1333
4. Wiese S., Breyer T., Dragu A., Wakili R., Burkard T., Schmidt-Schweda S., et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102 25 (2000) 3074-3079
5. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 1 (1994) 195-203
6. Dao Q., Krishnaswamy P., Kazanegra R., Harrison A., Amirnovin R., Lenert L., et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37 2 (2001) 379-385
7. McCullough P.A., Nowak R.M., McCord J., Hollander J.E., Herrmann H.C., Steg P.G., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106 4 (2002) 416-422
8. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 3 (2002) 161-167
9. Mueller C., Scholer A., Laule-Kilian K., Martina B., Schindler C., Buser P., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 7 (2004) 647-654
10. Clerico A., Fontana M., Zyw L., Passino C., and Emdin M. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem 53 5 (2007) 813-822
11. Mueller C., Breidthardt T., Laule-Kilian K., Christ M., and Perruchoud A.P. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 137 1-2 (2007) 4-12
12. O'Loughlin R., Allwright S., Barry J., Kelly A., and Teljeur C. Using HIPE data as a research and planning tool: limitations and opportunities. Ir J Med Sci 174 2 (2005) 40-45 discussion 52-7
13. Miller W.L., Burnett Jr. J.C., Hartman K.A., Henle M.P., Burritt M.F., and Jaffe A.S. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide. Am J Cardiol 96 6 (2005) 837-841
14. Doust J.A., Pietrzak E., Dobson A., and Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 7492 (2005) 625
15. Wijeysundera H.C., Hansen M.S., Stanton E., Cropp A.S., Hall C., Dhalla N.S., et al. Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J 146 2 (2003) 291-297
16. Selvais P.L., Robert A., Ahn S., van Linden F., Ketelslegers J.M., Pouleur H., et al. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail 6 3 (2000) 201-207
17. Masson S., Latini R., Anand I.S., Vago T., Angelici L., Barlera S., et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem 52 8 (2006) 1528-1538
18. van Kimmenade R.R., Januzzi Jr. J.L., Baggish A.L., Lainchbury J.G., Bayes-Genis A., Richards A.M., et al. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction?. J Am Coll Cardiol 48 8 (2006) 1621-1627
19. McKie P.M., Rodeheffer R.J., Cataliotti A., Martin F.L., Urban L.H., Mahoney D.W., et al. Hypertension 47 5 (2006) 874-880
20. Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., and Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293 13 (2005) 1609-1616
21. Morrow D.A., de Lemos J.A., Sabatine M.S., Murphy S.A., Demopoulos L.A., DiBattiste P.M., et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 41 8 (2003) 1264-1272
22. James S.K., Lindahl B., Siegbahn A., Stridsberg M., Venge P., Armstrong P., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108 3 (2003) 275-281
23. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 14 (2001) 1014-1021
24. Omland T., de Lemos J.A., Morrow D.A., Antman E.M., Cannon C.P., Hall C., et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 89 4 (2002) 463-465
25. Jernberg T., Stridsberg M., Venge P., and Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 40 3 (2002) 437-445
26. Bain M.R., Chalmers J.W., and Brewster D.H. Routinely collected data in national and regional databases - an under-used resource. J Public Health Med 19 4 (1997) 413-418
27. Berkelman R.L., and Buehler J.W. Public health surveillance of non-infectious chronic diseases: the potential to detect rapid changes in disease burden. Int J Epidemiol 19 3 (1990) 628-635